RxDoctor Payments DataLook up a doctor →

AMG334A_AIMOVIG_NEUROSCIENCE: payments to doctors

Payments that named AMG334A_AIMOVIG_NEUROSCIENCE as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$65K
Providers
7
Transactions
37
Average per transaction
$1,755

The per-transaction average — $1,755 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 7 providers the average total is $9,277, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Novartis Pharma AG$64,941100.0%
← All drugs & devices